Ad
related to: mymta beta 1 receptors
Search results
Results from the Go Local Guru Content Network
The beta-1 adrenergic receptor (β 1 adrenoceptor), also known as ADRB1, can refer to either the protein-encoding gene (gene ADRB1) or one of the four adrenergic receptors. It is a G-protein coupled receptor associated with the Gs heterotrimeric G-protein that is expressed predominantly in cardiac tissue.
The cellphone-friendly website and "MYmta" app, currently in a beta test phase, show straphangers real-time subway, bus and commuter rail information that has been housed in separate apps.
There are two main groups of adrenoreceptors, α and β, with 9 subtypes in total: α receptors are subdivided into α 1 (a G q coupled receptor) and α 2 (a G i coupled receptor) [7] α 1 has 3 subtypes: α 1A, α 1B and α 1D [a] α 2 has 3 subtypes: α 2A, α 2B and α 2C. β receptors are subdivided into β 1, β 2 and β 3.
Beta-1 adrenergic receptors are the primary receptor of the heart and, therefore, autoantibodies to these receptors have been tied to many different heart diseases. Autoantibodies to beta1-adrenergic receptors are linked to chronic heart failure.
MYmta is a mobile application-based passenger information display system developed by the Metropolitan Transportation Authority (MTA) of New York City. A beta version of the app was launched on July 2, 2018, and as of June 2019 [update] is still undergoing beta testing .
Metoprolol is a beta blocker, or an antagonist of the β-adrenergic receptors. It is specifically a selective antagonist of the β 1-adrenergic receptor and has no intrinsic sympathomimetic activity. Metoprolol exerts its effects by blocking the action of certain neurotransmitters, specifically adrenaline and noradrenaline.
TGFβ family receptors are grouped into three types, type I, type II, and type III. There are seven type I receptors, termed the activin-like receptors (ALK1–7), five type II receptors, and one type III receptor, for a total of 13 TGFβ superfamily receptors.
The melatonin receptors MT 1 and MT 2 are G-protein coupled receptors (GPCRs) that typically adhere to the cell's surface so that they can receive external melatonin signals. Binding of melatonin to the MT 1 receptor leads to inhibition of cAMP production and Protein Kinase A (PKA).
This page was last edited on 1 December 2007, at 08:14 (UTC).; Text is available under the Creative Commons Attribution-ShareAlike License 4.0; additional terms may apply.
MTA1 suppresses transcription of breast cancer type 1 susceptibility gene, PTEN, p21 WAF, guanine nucleotide-binding protein G(i) subunit alpha-2, SMAD family member 7, nuclear receptor subfamily 4 group A member 1, and homeobox protein SIX3, and represses BCL11B as well as E-cadherin expression.